The Leprosy Mission
The Leprosy Mission International is a UK-registered charity founded in 1874 that delivers integrated leprosy healthcare, scientific research, advocacy, and community empowerment services to persons affected by leprosy across more than 13 countries in Asia, Africa, and Oceania, funded through donations.
- Company typePrivate
- Founded1874
- HeadquartersBrentford, United Kingdom
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What The Leprosy Mission does
The Leprosy Mission International (TLM), founded in 1874 by Wellesley Bailey in Ireland and headquartered in Brentford, United Kingdom, is a registered charity (Charity No: 1076356, Company Registration no: 3591514) that delivers integrated leprosy healthcare, research, advocacy, and community empowerment services to persons affected by leprosy and their families across Asia, Africa, and Oceania. The organization operates hospitals, clinics, community projects, self-help groups, and vocational training centres through a global fellowship of country-level member organizations spanning at least 13 jurisdictions including India, Nepal, Bangladesh, Myanmar, Sri Lanka, the Philippines, Nigeria, Ethiopia, Mozambique, Niger, DR Congo, Papua New Guinea, and the United Kingdom, with associated fundraising presence in Australia, the USA, Brazil, and Paraguay.
TLM's core product set comprises direct healthcare services (hospitals and clinics such as Anandaban Hospital in Nepal, self-care programs, and healthcare-worker capacity building), a global research program conducted through dedicated laboratories (the Mycobacterial Research Laboratories at Anandaban Hospital, the Stanley Browne Laboratory in India, and the Field Research Programme in NW Bangladesh), and community empowerment initiatives including self-help groups, vocational training, mental health support, and a Leprosy Champions advocacy network. The technology stack supporting these activities is not proprietary; it consists of conventional digital channels (website, donation portal, newsletter, social media) layered onto established clinical and microbiological research infrastructure. Active R&D outputs include the L-PRF ulcer treatment and the ENLIST Consortium's clinical trials for Erythema Nodosum Leprosum, indicating an applied research-to-clinic translational pipeline.
As a non-profit, TLM's revenue model is donation-driven rather than commercial: services are provided free of charge to beneficiaries, and funding flows through national member organizations (e.g., TLM Great Britain, TLM Northern Ireland) and ancillary channels including TLM Trading Limited (a trading subsidiary) and The Leprosy Mission Shop (e-commerce retail). Specific revenue figures are not disclosed in the source material. Go-to-market is anchored on awareness campaigns (World Leprosy Day, World NTD Day, Global Day of Prayer), content marketing (the Duck Drop blog series, Leprosy Insights Magazine), a multi-platform social presence (Facebook, Instagram, LinkedIn, Twitter/X, TikTok, YouTube), and global advocacy at the United Nations and national governments led by the Global Advocacy Manager.
The Leprosy Mission firmographics
Firmographics- Name
- The Leprosy Mission
- Legal name
- The Leprosy Mission International
- Website
- https://leprosymission.org
- Company type
- Private
- Founded year
- 1874
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- The Leprosy Mission International is a UK-registered charity founded in 1874 that delivers integrated leprosy healthcare, scientific research, advocacy, and community empowerment services to persons affected by leprosy across more than 13 countries in Asia, Africa, and Oceania, funded through donations.
- Ownership category
- akta.pro rank
The Leprosy Mission industry classification
Industry- Product category
- Nonprofit Healthcare Services
- NAICS
- Religious, Grantmaking, Civic, Professional, and Similar Organizations (813), Scientific Research and Development Services (5417), Social Assistance (624)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- International & Local Implementing NGOs (HLAJAKAD)
- akta.pro secondary industries
- Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE), Injury Prevention, Disability & Rehabilitation Programs (BPADAIAM), Bilateral Development & Global Health Cooperation Programs (HLAJAOAB)
Keywords
Where The Leprosy Mission is headquartered
LocationHeadquarters
- HQ city
- Brentford
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
The Leprosy Mission business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Distribution channels5 records
Marketing channels12 records
The Leprosy Mission product offering
Product offeringCore offering
The Leprosy Mission provides free leprosy healthcare, rehabilitation, and preventive services through a network of hospitals, clinics, and community programs across Asia, Africa, and Australasia. It conducts scientific research on leprosy diagnostics, transmission, and treatment at dedicated laboratories in Nepal, India, and Bangladesh, and runs vocational training and self-help group programs to support the economic and social inclusion of persons affected by leprosy and their families.
Product overview
The Leprosy Mission operates as a charitable organization with a digital platform that combines informational resources, donation processing, newsletter distribution, and advocacy programs. The core offering consists of integrated healthcare services (hospitals, clinics, self-care programs), global research programs conducted across Nepal, India, Bangladesh, Nigeria, and Ethiopia, and community empowerment initiatives including Vocational Training Centres and Self-Help Groups. Supporting programs include the ENLIST Consortium for ENL research, the Leprosy Champions advocacy network, the quarterly Leprosy Insights Magazine, and the annual Global Day of Prayer. The L-PRF ulcer treatment represents an innovative medical intervention emerging from their research pipeline.
Differentiator
Problem solved
Functional benefit
Products and services
- Leprosy Healthcare Services
- TLM Research Programs
- Vocational Training Centres (VTC)
Quantifiable outcome
- Around 200,000 people are diagnosed with leprosy every year
- +4 more outcomes
Companies that use The Leprosy Mission
Customer profileSegments1 record
Ideal customer profiles3 records
The Leprosy Mission technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
The Leprosy Mission partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights6 records
The Leprosy Mission competitors and assessment
Company assessmentDirect peers
- American Leprosy Missions: US-based Christian NGO working exclusively on leprosy and NTDs through healthcare, research, and advocacy. Directly comparable to TLM in mission, beneficiary base, and operating model across leprosy-endemic countries.
- Netherlands Leprosy Relief (NLR): Dutch INGO that was a co-founder of the international leprosy response and operates direct programs in leprosy-endemic countries. Closely comparable in mission, geographic footprint, and combination of service delivery, research, and advocacy.
- LEPRA: UK-registered leprosy-focused INGO providing diagnosis, treatment, disability prevention, and community reintegration in Asia and Africa. Direct peer in disease focus, beneficiary population, and UK-based fundraising footprint.
- FAIRMED: Swiss INGO focused on leprosy and other NTDs in Asia, Africa, and Latin America through community-based rehabilitation and inclusive development. Comparable in delivery model and beneficiary population, with overlapping country presence.
- Effect:Hope (formerly The Leprosy Mission Canada): Canadian INGO historically affiliated with the TLM fellowship, focused on leprosy, NTDs, and disability inclusion in Africa and Asia. Direct peer across disease focus, program design, and donor base.
- Damien Foundation: Belgian INGO providing leprosy diagnosis, treatment, and rehabilitation across Asia, Africa, and Latin America. Comparable in vertical integration (hospitals, field programs, research support) and in leprosy-only mission.
Broad incumbents
- Sasakawa Health Foundation: Japan-based foundation working on leprosy, NTDs, and human rights globally in partnership with WHO. Operates as a major funder/coordinator rather than primary service provider, but shapes the same leprosy agenda TLM pursues.
- Novartis Foundation: Pharma-affiliated foundation that has historically funded free MDT for leprosy worldwide and partners with WHO on NTD programs. Comparable as a system-level actor in the leprosy response, but with much broader health portfolio.
- World Health Organization (NTD Department): UN agency setting the global NTD and leprosy strategy, normative guidance, and treatment standards that TLM's programs implement. Comparable as a leprosy/NTD stakeholder but functions as policy setter rather than field operator.
Others
- International Federation of Anti-Leprosy Associations (ILEP): Umbrella federation of which TLM and most direct peers above are members, coordinating leprosy policy, joint programming, and advocacy. Comparable as a coordinating body in the leprosy ecosystem that TLM operates within.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
The Leprosy Mission social profiles
Digital presenceThe Leprosy Mission financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Leprosy Mission leadership team
Management profileNumber of profiles
Profiles5 records
The Leprosy Mission subsidiaries and ownership
Company hierarchySubsidiaries14 records
The Leprosy Mission funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Leprosy Mission M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Leprosy Mission
What does The Leprosy Mission do?
The Leprosy Mission provides free leprosy healthcare, rehabilitation, and preventive services through a network of hospitals, clinics, and community programs across Asia, Africa, and Australasia. It conducts scientific research on leprosy diagnostics, transmission, and treatment at dedicated laboratories in Nepal, India, and Bangladesh, and runs vocational training and self-help group programs to support the economic and social inclusion of persons affected by leprosy and their families.
Is The Leprosy Mission a public or private company?
The Leprosy Mission is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Leprosy Mission founded?
The Leprosy Mission was founded in 1874. It employs 501 to 1,000 people.
Where is The Leprosy Mission based?
The Leprosy Mission is headquartered in Brentford, United Kingdom, in the Europe region.
Who are The Leprosy Mission's main competitors?
Direct peers on record are American Leprosy Missions, Netherlands Leprosy Relief (NLR), LEPRA, FAIRMED, Effect:Hope (formerly The Leprosy Mission Canada) and Damien Foundation. Broad incumbents are Sasakawa Health Foundation, Novartis Foundation and World Health Organization (NTD Department). International Federation of Anti-Leprosy Associations (ILEP) is listed as an others.
Does The Leprosy Mission have an API?
No public API is recorded for The Leprosy Mission.
What industry is The Leprosy Mission in?
The Leprosy Mission's product category is Nonprofit Healthcare Services. Its primary akta.pro industry code is HLAJAKAD, International & Local Implementing NGOs, with a secondary code of HLAJAOAE, Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs). Its NAICS code is 813 and its SIC code is 8000.